VEGFA and glioblastoma: Autopsy tissues from recurrent glioblastoma multiforme (rGBM) patients treated with pan-VEGF receptor tyrosine kinase inhibitor cediranib were compared to tissue from rGBM patients with standard care (surgery, radiation, and chemotherapy).